sellWeak cluster of 510b5-1 plan
Melissa M. Tomkiel sold $113k of SRTA
President and General Counsel at Strata Critical Medical, Inc.. 22,486 shares at an average of $5.01, traded Dec 9, 2024, filed Dec 11, 2024.
Warning score
25Value
$113k
22,486 shares
Holdings after
1,039,140
-2% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +20RolePresident
- +10Trade size$113k at market
- 0Share of holdings soldSold 2.1% of holdings
- +15Cluster5 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001779128-24-000154, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 9, 2024 | SOpen-market sale Class A common stock, $0.0001 par value per share10b5-1 | -22,486 | $5.01 | $113k | 1,039,140 | Dec 11, 2024 |
| Dec 11, 2024 | FTax withholding Class A common stock, $0.0001 par value per share10b5-1 | -34,018 | $4.72 | $161k | 1,005,122 | Dec 11, 2024 |
Related signals
Other insiders at Strata Critical Medical, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | Strata Critical Medical, Inc. | William A. Heyburn Co-CEO and CFO | $76k 17,000 shares | +1% | |
| 27Weak | Strata Critical Medical, Inc. | Andrew Lauck director | $22k 5,000 shares | +4% | |
| 22Weak | SRTAsell Strata Critical Medical, Inc. | Reginald Love director | $48k 11,000 shares | -9% | |
| 21Weak | SRTAsell Strata Critical Medical, Inc. | Reginald Love director | $47k 11,000 shares | -8% | |
| 23Weak | Strata Critical Medical, Inc. | William A. Heyburn Chief Financial Officer | $232k 46,918 shares | -3% | |
| 21Weak | Strata Critical Medical, Inc. | Melissa M. Tomkiel President and General Counsel | $237k 47,995 shares | -4% | |
| 26Weak | Strata Critical Medical, Inc. | William A. Heyburn Chief Financial Officer | $407k 100,000 shares | -7% | |
| 24Weak | Strata Critical Medical, Inc. | Melissa M. Tomkiel President and General Counsel | $408k 100,000 shares | -8% | |
| 5Weak | Strata Critical Medical, Inc. | William A. Heyburn Chief Financial Officer | $525k 104,570 shares | -8% | |
| 39Weak | Strata Critical Medical, Inc. | John Borthwick director | $313k 78,291 shares | -32% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.